| Susan Badidi, MD | |
|
101 S Hartford St, Breckenridge, TX 76424-4711 | |
| (254) 559-3363 | |
| (254) 559-2572 |
| Full Name | Susan Badidi |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 101 S Hartford St, Breckenridge, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184989642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | Q5745 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jps Health Network | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Acclaim Physician Group Inc | 4587963582 | 439 |
News Archive
National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.
Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.
Most hospitals have implemented electronic medical records, but only 24% of consumers are making use of them, a new study shows. Hospital CIOs are working on ways to boost adoption of EMRs, which have been tied to improvements in health care, as well as billions of dollars in federal incentive payments.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
› Verified 7 days ago
| Entity Name | Acclaim Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.
Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.
Most hospitals have implemented electronic medical records, but only 24% of consumers are making use of them, a new study shows. Hospital CIOs are working on ways to boost adoption of EMRs, which have been tied to improvements in health care, as well as billions of dollars in federal incentive payments.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
› Verified 7 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20190520001486 |
News Archive
National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.
Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.
Most hospitals have implemented electronic medical records, but only 24% of consumers are making use of them, a new study shows. Hospital CIOs are working on ways to boost adoption of EMRs, which have been tied to improvements in health care, as well as billions of dollars in federal incentive payments.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Badidi, MD 101 S Hartford St, Breckenridge, TX 76424-4711 Ph: (254) 559-3363 | Susan Badidi, MD 101 S Hartford St, Breckenridge, TX 76424-4711 Ph: (254) 559-3363 |
News Archive
National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice.
Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.
Most hospitals have implemented electronic medical records, but only 24% of consumers are making use of them, a new study shows. Hospital CIOs are working on ways to boost adoption of EMRs, which have been tied to improvements in health care, as well as billions of dollars in federal incentive payments.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
› Verified 7 days ago
Kelli Windsor, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 S Hartford St, Breckenridge, TX 76424 Phone: 254-559-3363 Fax: 254-559-2547 | |
Kaitlyn Nicole Welch, Family Medicine Medicare: Medicare Enrolled Practice Location: 2802 W Walker St, Breckenridge, TX 76424 Phone: 254-559-7215 | |
Alexandra Bernadette Arce, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 S Geneva St, Breckenridge, TX 76424 Phone: 817-368-0320 | |
William Elmo Prater, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 S Hartford St, Breckenridge, TX 76424 Phone: 254-559-3363 Fax: 254-559-7079 |